Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : IPT-001
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Serum Institute of India
Deal Size : $11.7 million
Deal Type : Series A Financing
HERVolution Secures $11.7M Series A for Cancer and Aging Disease Treatments
Details : The financing will support the company-lead product IPT-001 to advance the clinical development for the treatment of HERVs prostate and pancreatic cancer.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
December 19, 2024
Lead Product(s) : IPT-001
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Serum Institute of India
Deal Size : $11.7 million
Deal Type : Series A Financing